Pharmaceuticals 2011 - Residual Solvents: Practical Strategies for Compliance
Date2011-04-12
Deadline2011-04-12
VenuePalo Alto, USA - United States
KeywordsPharmaceuticals,conference,event,Webinar
Topics/Call fo Papers
Why Should You Attend:
Compliance with compendial standards for residual solvents is required for all drug products provided in the United States, and similar requirements exist in all the major markets of the world. Since every product is unique, and since the requirements refer to over 50 different solvents, achieving compliance can be very challenging. Many, many firms have received incomplete or warning letters from the FDA as a result of failure to adequately address the reporting of residual solvents.
This course is designed to provide participants with practical strategies for complying with regulatory requirements for residual solvents while minimizing resource requirements. The course will address FDA expectations, understanding the potential sources of residual solvents in drug products, appropriate analytical methodology and strategies for characterizing solvents in components and in drug product. The course will address reporting levels of residual solvents, and conclude with an opportunity for questions and answers.
At the end of this training you will be armed with an understanding of the expectations and approaches which have been successfully accepted by regulatory agencies, you can anticipate success in meeting the compliance requirements while significantly reducing the resources necessary to comply, when compared with a straightforward application of the compendial requirements.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
Compliance with compendial standards for residual solvents is required for all drug products provided in the United States, and similar requirements exist in all the major markets of the world. Since every product is unique, and since the requirements refer to over 50 different solvents, achieving compliance can be very challenging. Many, many firms have received incomplete or warning letters from the FDA as a result of failure to adequately address the reporting of residual solvents.
This course is designed to provide participants with practical strategies for complying with regulatory requirements for residual solvents while minimizing resource requirements. The course will address FDA expectations, understanding the potential sources of residual solvents in drug products, appropriate analytical methodology and strategies for characterizing solvents in components and in drug product. The course will address reporting levels of residual solvents, and conclude with an opportunity for questions and answers.
At the end of this training you will be armed with an understanding of the expectations and approaches which have been successfully accepted by regulatory agencies, you can anticipate success in meeting the compliance requirements while significantly reducing the resources necessary to comply, when compared with a straightforward application of the compendial requirements.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.
Other CFPs
- A Comparison in Terms and Application for Drugs and Biologics
- QbD Approach to Analytical Method Lifecycle - Webinar By ComplianceOnline
- Annex 13 GMP guide - Webinar By ComplianceOnline
- Anatomy of a Medical Device Inspection - Webinar By ComplianceOnline
- Tips on Writing the Perfect Document to Impress the FDA
Last modified: 2011-02-14 18:16:28